These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 19621590)

  • 1. [Establishment of a GFP-based cellular model for screening novel proteasome inhibitors].
    Fang H; Hu Z; Zhou G
    Sheng Wu Gong Cheng Xue Bao; 2009 Mar; 25(3):452-6. PubMed ID: 19621590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of reporter gene-based cell screening model for discovering new chemopreventive agents].
    Xu H; Bu P; Li X
    Zhongguo Zhong Yao Za Zhi; 2009 Jul; 34(14):1835-9. PubMed ID: 19894520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A; Man S; Elliott P; Adams J; Kerbel RS
    Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
    Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ
    Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM).
    Yin D; Zhou H; Kumagai T; Liu G; Ong JM; Black KL; Koeffler HP
    Oncogene; 2005 Jan; 24(3):344-54. PubMed ID: 15531918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment of high-throughput drug screening model targeting retinoic acid receptor in cells].
    Guo F; Liu YX; Zheng DX; Jiang CY
    Yao Xue Xue Bao; 2005 Oct; 40(10):908-11. PubMed ID: 16408807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
    Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
    Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibition: mechanism of action.
    DeMartino GN
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S5-9. PubMed ID: 19791423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells.
    Qin JZ; Ziffra J; Stennett L; Bodner B; Bonish BK; Chaturvedi V; Bennett F; Pollock PM; Trent JM; Hendrix MJ; Rizzo P; Miele L; Nickoloff BJ
    Cancer Res; 2005 Jul; 65(14):6282-93. PubMed ID: 16024630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.
    Meister S; Schubert U; Neubert K; Herrmann K; Burger R; Gramatzki M; Hahn S; Schreiber S; Wilhelm S; Herrmann M; Jäck HM; Voll RE
    Cancer Res; 2007 Feb; 67(4):1783-92. PubMed ID: 17308121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of GFP-AWP1 fusion gene vector and its expression in 293 cells].
    Cao YK; Mo YY; Tian FZ; Liu YW; Deng P; Qin QH; Jiang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):174-6, 180. PubMed ID: 15698998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving disease biology from the lab to the clinic.
    Anderson KC
    Cancer; 2003 Feb; 97(3 Suppl):796-801. PubMed ID: 12548578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transduction of recombinant marrow stem cells using lentiviral vector and adenoviral vector: a comparative study].
    Ma XS; Jiang JY; Lü FZ; Ma X; Li XK; Huang HY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3340-4. PubMed ID: 17313830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
    Ramezani A; Hawley TS; Hawley RG
    Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.
    LeBlanc R; Catley LP; Hideshima T; Lentzsch S; Mitsiades CS; Mitsiades N; Neuberg D; Goloubeva O; Pien CS; Adams J; Gupta D; Richardson PG; Munshi NC; Anderson KC
    Cancer Res; 2002 Sep; 62(17):4996-5000. PubMed ID: 12208752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
    Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
    Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibition blocks ligand-induced dynamic processing and internalization of epidermal growth factor receptor via altered receptor ubiquitination and phosphorylation.
    Kesarwala AH; Samrakandi MM; Piwnica-Worms D
    Cancer Res; 2009 Feb; 69(3):976-83. PubMed ID: 19176375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.